HR 1734 118th Congress

TRANQ Research Act of 2023

Latest Action

Became Public Law No: 118-23.

Congress.gov

Sponsors

Rep. Collins, Mike [R-GA-10]

Rep. Collins, Mike [R-GA-10]

R — GA

Summary

Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.
Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.
Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.
Testing, Rapid Analysis, and Narcotic Quality Research Act or the TRANQ Research Act This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other emerging substances of concern. In particular, NIST must support basic measurement science and research, including graduate and postgraduate research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.
Testing, Rapid Analysis, and Narcotic Quality Research Act or the TRANQ Research Act This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other emerging substances of concern. In particular, NIST must support basic measurement science and research, including graduate and postgraduate research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.
Testing, Rapid Analysis, and Narcotic Quality Research Act or the TRANQ Research Act This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other emerging substances of concern. In particular, NIST must support basic measurement science and research, including graduate and postgraduate research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.

Vote Result

Passed House

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

Actions

2023-12-19T00:00:00

Became Public Law No: 118-23.

2023-12-19T00:00:00

Became Public Law No: 118-23.

2023-12-19T00:00:00

Signed by President.

2023-12-19T00:00:00

Signed by President.

2023-12-14T00:00:00

Presented to President.

2023-12-14T00:00:00

Presented to President.

2023-12-04T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2023-12-04T00:00:00

On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H6087-6088)

2023-12-04T00:00:00

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H6087-6088)

2023-12-04T00:00:00

DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendment to H.R. 1734.

2023-12-04T00:00:00

Mr. Lucas moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H6087-6089)

2023-06-26T00:00:00

Message on Senate action sent to the House.

2023-06-22T00:00:00

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S2250-2251)

2023-06-22T00:00:00

Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S2250-2251)

2023-06-22T00:00:00

Measure laid before Senate by unanimous consent. (consideration: CR S2250)

2023-05-15T00:00:00

Received in the Senate, read twice.

2023-05-11T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2023-05-11T00:00:00

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

2023-05-11T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

2023-05-11T00:00:00

Considered as unfinished business. (consideration: CR H2295-2296)

2023-05-09T00:00:00

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

2023-05-09T00:00:00

DEBATE - The House proceeded with forty minutes of debate on H.R. 1734.

2023-05-09T00:00:00

Considered under suspension of the rules. (consideration: CR H2149-2151)

2023-05-09T00:00:00

Mr. Miller (OH) moved to suspend the rules and pass the bill, as amended.

2023-05-05T00:00:00

Placed on the Union Calendar, Calendar No. 34.

2023-05-05T00:00:00

Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

2023-05-05T00:00:00

Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

2023-03-29T00:00:00

Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 0.

2023-03-29T00:00:00

Committee Consideration and Mark-up Session Held.

2023-03-23T00:00:00

Referred to the House Committee on Science, Space, and Technology.

2023-03-23T00:00:00

Introduced in House

2023-03-23T00:00:00

Introduced in House

Policy Areas

Science, Technology, Communications

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play